Current Edition

Early-stage Development, Xcelodose & Clinical Phases
Editorial Archive

Early-stage Development, Xcelodose & Clinical Phases

The pharmaceutical industry’s ongoing demand to shorten drug development times, thus making significant cost savings, is driving technological advances forward at the...
Continue Reading →
Driving by Data: A Faster, Better Road to Market
Editorial Archive

Driving by Data: A Faster, Better Road to Market

The clinical development path is rife with complexity that can stall or stop a drug’s journey to market. Paul Evans, Jeetendra Rao and Abigaile Betteridge at PAREXEL ...
Continue Reading →
Enrolment Compliance and Study Data
Editorial Archive

Enrolment Compliance and Study Data

The current concept of clinical trial conduct is a balance between benefits from treatment (efficacy) and risks that this treatment may have (risk). Maxim Kosov, Tati...
Continue Reading →
Clinical Development in Challenging Cancers: Primary Bone  Sarcomas
Editorial Archive

Clinical Development in Challenging Cancers: Primary Bone Sarcomas

Primary bone sarcomas are cancers of mesenchymal, non-epithelial derivation, originating from bone cells or their precursors. Kelechi K. Olu MD, MSc, Vijayanand Rajen...
Continue Reading →
Three Respiratory Trial Strategies that Won’t Leave You  Breathless
Editorial Archive

Three Respiratory Trial Strategies that Won’t Leave You Breathless

The biopharmaceutical industry invests billions of dollars annually into clinical research to address a range of debilitating respiratory conditions. Phil Lake at ERT...
Continue Reading →
Augmenting Clinical Development of Heart Failure Therapies
Editorial Archive

Augmenting Clinical Development of Heart Failure Therapies

There are currently a number of pharmaceutical or device-based heart failure therapies in clinical use, with numerous promising candidates under development. Bobby St...
Continue Reading →
Potential Therapies in the R&D Pipeline for  Facioscapulohumeral Muscular Dystrophy
Editorial Archive

Potential Therapies in the R&D Pipeline for Facioscapulohumeral Muscular Dystrophy

Facioscapulohumeral MD, likely the most prevalent form of MD, currently has no cure, but several factors point to the potential for successful development of a diseas...
Continue Reading →
Healthcare Research in United Arab Emirates
Editorial Archive

Healthcare Research in United Arab Emirates

The UAE has rapidly transformed its healthcare sector in the past decade. Adhiti Sharad Kumar explains the UAE’s 2021 Vision, which states that the UAE will invest co...
Continue Reading →
A Decade of Biosimilars: Have Expectations Been Met?
Editorial Archive

A Decade of Biosimilars: Have Expectations Been Met?

Innovator companies have employed a variety of multipronged strategies to counter biosimilar competition. These include development of ‘biobetter’, gaining regulatory...
Continue Reading →
Clinical Trial’s Role in Compliance and Patient Safety
Editorial Archive

Clinical Trial’s Role in Compliance and Patient Safety

Although James Lind conducted the first controlled clinical trial back in 1747, it wasn’t until the Nuremberg Code in 1947 and the Declaration of Helsinki in 1964 tha...
Continue Reading →